Pharmacokinetic-pharmacodynamic relationship of arbekacin for treatment of patients infected with methicillin-resistant Staphylococcus aureus.
Sato R, Tanigawara Y, Kaku M, Aikawa N, Shimizu K.
Sato R, et al.
Antimicrob Agents Chemother. 2006 Nov;50(11):3763-9. doi: 10.1128/AAC.00480-05.
Antimicrob Agents Chemother. 2006.
PMID: 17065622
Free PMC article.
Clinical Trial.
Since we have reported the population pharmacokinetic parameters for arbekacin in the preceding paper (Y. Tanigawara, R. Sato, K. Morita, M. Kaku, N. Aikawa, and K. Shimizu, Antimicrob. Agents Chemother. 50:3754-3762, 2006), individual exposure parameters, such as a …
Since we have reported the population pharmacokinetic parameters for arbekacin in the preceding paper (Y. Tanigawara, R. Sato, …